Cargando…

Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device

PURPOSE: Poor adherence to recombinant human growth hormone (r-hGH) therapy is associated with reduced growth velocity in children with growth hormone deficiency (GHD). This twelve-month observational study was to assess adherence in r-hGH patients treated with the easypod(™), an electronic, fully a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loche, S., Salerno, M., Garofalo, P., Cardinale, G. M., Licenziati, MR, Citro, G., Caruso Nicoletti, M., Cappa, M., Longobardi, S., Maghnie, M., Perrone, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107197/ https://www.ncbi.nlm.nih.gov/pubmed/27406716 http://dx.doi.org/10.1007/s40618-016-0510-0

Ejemplares similares

Easypod(TM) adherence in children with growth disorders treated with r-hGH. A preliminary Italian experience
por: Loche, Sandro, et al.
Publicado: (2013)

Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS)
por: Centonze, C., et al.
Publicado: (2019)

SUN-260 The Severity of GH Deficiency (GHD) Does Not Affect Adherence to Treatment in GHD Prepubertal Children Taking rh-GH via the Easypod Device
por: Loche, Sandro, et al.
Publicado: (2019)

Adherence to r-hGH Therapy in Pediatric Growth Hormone Deficiency: Current Perspectives on How Patient-Generated Data Will Transform r-hGH Treatment Towards Integrated Care
por: Savage, Martin O, et al.
Publicado: (2022)

Quantifying adherence to growth hormone treatment: the easypod™ connect observational study (ECOS)
por: Davies, Peter, et al.
Publicado: (2013)

Intranasal Human Growth Hormone (hGH) Induces IGF-1 Levels Comparable With Subcutaneous Injection With Lower Systemic Exposure to hGH in Healthy Volunteers
por: Lewis, Andrew L., et al.
Publicado: (2015)

Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy
por: Foo, Jason, et al.
Publicado: (2019)

Preclinical and Clinical In Vitro In Vivo Correlation of an hGH Dextran Microsphere Formulation
por: Vlugt-Wensink, K. D. F., et al.
Publicado: (2007)

What Factors Spur a Short Individual's Response to Human GH (hGH)?
por: Rogol, Alan D
Publicado: (2023)

Accuracy and Limitations of the Growth Hormone (GH) Releasing Hormone-Arginine Retesting in Young Adults With Childhood-Onset GH Deficiency
por: Patti, Giuseppa, et al.
Publicado: (2019)

Isolation and Characterization of the Arapaima gigas Growth Hormone (ag-GH) cDNA and Three-Dimensional Modeling of This Hormone in Comparison with the Human Hormone (hGH)
por: Lima, Eliana Rosa, et al.
Publicado: (2023)

Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre
por: Maggio, Maria Cristina, et al.
Publicado: (2018)

The adult growth hormone multicentric retrospective observational study: a 24-month Italian experience of adherence monitoring via Easypod™ of recombinant growth hormone treatment in adult GH deficiency
por: Mancini, Antonio, et al.
Publicado: (2023)

Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study
por: Cappa, M., et al.
Publicado: (2015)

PMON68 Effect of an Amino-Acid Based Blend on Human Growth Hormone (hGH) and Fibromyalgia (FM) Symptoms
por: Beres, Adam, et al.
Publicado: (2022)

SUN-256 Limited Usefulness of Single IGF-I Measurement as a Screening Test for Growth Hormone Deficiency in Children and Adolescents
por: Ibba, Anastasia, et al.
Publicado: (2019)

Adherence and long-term outcomes of growth hormone therapy with easypod™ in pediatric subjects: Spanish ECOS study
por: Rodríguez Arnao, María Dolores, et al.
Publicado: (2019)

Cell-specific expression of alpha 1(I) collagen-hGH minigenes in transgenic mice
Publicado: (1994)

Testosterone, cortisol, hGH, and IGF‐1 levels in an Italian female elite volleyball team
por: Roli, Laura, et al.
Publicado: (2018)

Efficacy and Safety of up to 2 Years of Treatment With TransCon hGH (Lonapegsomatropin) in Treatment-Naïve and Treatment-Experienced Children With Growth Hormone Deficiency
por: Maniatis, Aristides K, et al.
Publicado: (2021)

Iontophoretic Transdermal Delivery of Human Growth Hormone (hGH) and the Combination Effect of a New Type Microneedle, Tappy Tok Tok(®)
por: Noh, Gyubin, et al.
Publicado: (2018)

PLGA Microspheres of hGH of Preserved Native State Prepared Using a Self-Regulated Process
por: Diana, Jebun Nessa, et al.
Publicado: (2020)

Monitoring Adherence Rate to Growth Hormone Therapy and Growth Outcomes in Taiwanese Children Using Easypod Connect: Observational Study
por: Su, Pen-Hua, et al.
Publicado: (2021)

Solid-Phase Synthesis of an “Inaccessible” hGH-Derived Peptide Using a Pseudoproline Monomer and SIT-Protection for Cysteine
por: Manne, Srinivasa Rao, et al.
Publicado: (2022)

SUN-464 Trunk Fat Increase Is Prevented Both in Patients Undergoing Long-Lasting Continuous r-hGH Therapy and in Those Who Discontinued r-hGH Compared to Untreated Patients: Results from Baseline Data of the MAGHD Study
por: Monzani, Maria Laura, et al.
Publicado: (2019)

Treatment adherence with the easypod™ growth hormone electronic auto-injector and patient acceptance: survey results from 824 children and their parents
por: Bozzola, Mauro, et al.
Publicado: (2011)

Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS)
por: Blanco-López, A., et al.
Publicado: (2020)

OR10-04 Interpretation of Insulin-like Growth Factor-1 (IGF-1) Levels Following Administration of Somatrogon (a Long-acting Human Growth Hormone - hGH-CTP)
por: Fisher, Dennis M, et al.
Publicado: (2020)

Relevance of Adherence Monitoring in Adult Patients With Growth Hormone Deficiency Under Replacement Therapy: Preliminary Monocentric Data With Easypod(TM) Connect
por: Mancini, Antonio, et al.
Publicado: (2019)

Patients' Perception of the Use of the EasyPod™ Growth Hormone Injector Device and Impact on Injection Adherence: A Multi-Center Regional Study
por: Deeb, Asma, et al.
Publicado: (2022)

Diagnosis of GH Deficiency Without GH Stimulation Tests
por: Ibba, Anastasia, et al.
Publicado: (2022)

Autocrine hGH stimulates oncogenicity, epithelial-mesenchymal transition and cancer stem cell-like behavior in human colorectal carcinoma
por: Wang, Jing-Jing, et al.
Publicado: (2017)

Positive Impact of Targeted Educational Intervention in Children With Low Adherence to Growth Hormone Treatment Identified by Use of the Easypod™ Electronic Auto-injector Device
por: Assefi, Aria Reza, et al.
Publicado: (2021)

SAT-LB16 Maintenance of Favorable Treatment Effect of Once-Weekly TransCon hGH for Children With Growth Hormone Deficiency: Interim Analysis From the Enlighten Long-Term Extension Trial
por: Maniatis, Aristides K, et al.
Publicado: (2020)

IGF1 for the diagnosis of growth hormone deficiency in children and adolescents: a reappraisal
por: Ibba, Anastasia, et al.
Publicado: (2020)

Extensive phenotypic characterization of a new transgenic mouse reveals pleiotropic perturbations in physiology due to mesenchymal hGH minigene expression
por: Kaklamanos, Aimilios, et al.
Publicado: (2017)

Adherence and long-term growth outcomes: results from the easypod(™) connect observational study (ECOS) in paediatric patients with growth disorders
por: Koledova, Ekaterina, et al.
Publicado: (2018)

Yearly Height Gain Is Dependent on the Truly Received Dose of Growth Hormone and the Duration of Periods of Poor Adherence: Practical Lessons From the French Easypod™ Connect Multicenter Observational Study
por: Coutant, Régis, et al.
Publicado: (2022)

Quality of life in children and adolescents with growth hormone deficiency and their caregivers: an Italian survey
por: Maghnie, M., et al.
Publicado: (2023)

Design of the ForesiGHt Trial: A Multicenter, Randomized, Placebo- and Active-Controlled Trial to Compare Once-Weekly TransCon hGH (lonapegsomatropin) to Placebo and Daily Somatropin in Adults With Growth Hormone Deficiency (GHD)
por: Fleseriu, Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eat9eigts0v39dtdrvsam0q12f